Heart failure with preserved systolic function of the left ventricle

Česká verzia

Authors: V. Melenovský
Authors place of work: Klinika kardiologie ; Přednosta: prof. MUDr. Josef Kautzner, DrSc. ; Institut klinické a experimentální medicíny, Praha
Published in the journal: Prakt. Lék. 2010; 90(4): 235-238
Category: Of different specialties

Summary

It has been increasingly recognized that almost half of patients hospitalized for heart failure have relatively preserved systolic function of the left ventricle. The prevalence of this type of heart failure is increasing and the long-term prognosis is similarly unfavourable as in systolic dysfunction. In its typical form, this disease occurs in older patients, more often in females, with a long history of arterial hypertension and/or diabetes, who have concentric left ventricular hypertrophy or remodelling, dilated left atrium and abnormalities of diastolic ventricular filling. Despite being a relatively common disease, its pathophysiology has not yet been completely elucidated. Besides abnormal diastolic ventricular properties and decreased contractile reserve, other extraventricular mechanisms are equally relevant - such as increased stiffness of large arteries, abnormal mechanical function of the left atrium and abnormal autonomic cardiovascular control.

Long-term care consists of managing fluid retention with diuretics and meticulous control of hypertension, preferably with drugs with proven capacity to regress left ventricular hypertrophy. It can be expected that the current intensive research on this condition will identify critical mechanisms responsible for the pathophysiology, which will ultimately lead to more specific and causal therapies.

Key words:
heart failure, ejection fraction, diastolic dysfunction, arterial hypertension, left ventricular hypertrophy.

Zdroje

1. Lenzen, M.J., Scholte op Reimer, W.J., Boersma, E. et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur. Heart J. 2004, 25(14), p. 1214-1220.

2. Yancy, C.W., Lopatin, M., Stevenson, L.W. et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J. Am. Coll. Cardiol. 2006, 47(1), p. 76-84.

3. Liao, L., Jollis, J.G., Anstrom, K.J. et al. Costs for heart failure with normal vs. reduced ejection fraction. Arch. Intern. Med. 2006, 166(1), p. 112-118.

4. Owan, T.E., Hodge, D.O., Herges, R.M. et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 2006, 355(3), p. 251-259.

5. Swedberg, K., Cleland, J., Dargie, H. et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur. Heart J. 2005, 26(11), p. 1115-1140.

6. Zile, M.R., Baicu, C.F., Gaasch, W.H. Diastolic heart failure—abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med. 2004, 350(19), p. 1953-1959.

7. Kawaguchi, M., Hay, I., Fetics, B. et al. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107(5), p. 714-720.

8. Redfield, M.M., Jacobsen, S.J., Burnett, J.C. Jr. et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003, 289(2), p. 194-202.

9. Heart Failure Society Of America. Evaluation and management of patients with heart failure and preserved left ventricular ejection fraction. J. Card. Fail. 2006, 12(1), e80-e85.

10. Yu, C.M., Lin, H., Yang, H. et al. Progression of systolic abnormalities in patients with “isolated” diastolic heart failure and diastolic dysfunction. Circulation 2002, 105(10), p. 1195-1201.

11. Borlaug, B.A., Melenovsky, V., Russell, S.D. et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114(20), p. 2138-2147.

12. Melenovsky, V., Borlaug, B.A., Rosen, B. et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J. Am. Coll. Cardiol. 2007, 49(2), p. 198-207.

13. Zieman, S.J., Melenovsky, V., Kass, D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler. Thromb. Vasc. Biol. 2005, 25(5), p. 932-943.

14. Leite-Moreira, A.F., Correia-Pinto, J., Gillebert, T.C. Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction. Cardiovasc. Res. 1999, 43(2), p. 344-353.

15. Chen, CH., Nakayama, M., Nevo, E. et al. Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. J. Am. Coll. Cardiol. 1998, 32(5), p. 1221-1227.

16. Paulus, W.J., Tschope, C., Sanderson, J.E. et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart. J. 2007, 28(20), p. 2539-2550.

17. Bruch, C., Grude, M., Muller, J. et al. Usefulness of tissue Doppler imaging for estimation of left ventricular filling pressures in patients with systolic and diastolic heart failure. Am. J. Cardiol. 2005, 95(7), p. 892-895.

18. Maisel, A.S., McCord, J., Nowak, R.M. et al. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. J. Am. Coll. Cardiol. 2003, 41(11), p. 2010-2017.

19. Lam, C.S., Roger, V.L., Rodeheffer, R.J. et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J. Am. Coll. Cardiol. 2009, 53(13), p. 1119-1126.

20. Nieminen, M.S., Bohm, M., Cowie, M.R. et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur. Heart J. 2005, 26(4), p. 384-416.

21. Špinar, J., Hradec, J., Meluzín, J. Doporučení pro diagnostiku a léčbu chronického srdečního selhání ČKS 2006. Cor. Vasa 2007, 49(1), K5-K34.

22. Davis, B.R., Kostis, J.B., Simpson, L.M. et al. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation 2008, 118(22), p. 2259-2267.

23. Devereux, R.B., Dahlof, B., Gerdts, E. et al. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 2004, 110(11), p. 1456-1462.

24. Yusuf, S., Pfeffer, M.A., Swedberg, K. et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362(9386), p. 777-781.

25. Cleland, J.G., Tendera, M., Adamus, J. et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur. Heart J, 2006, 27(19), p. 2338-2345.

26. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 1997, 336(8), p. 525-533.

27. Flather, M.D., Shibata, M.C., Coats, A.J. et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur. Heart J. 2005, 26(3), p. 215-225.

28. Kass, D.A., Bronzwaer, J.G., Paulus, W.J. What mechanisms underlie diastolic dysfunction in heart failure? Circ. Res. 2004, 94(12), p. 1533-1542.

29. Hundley, W.G., Kitzman, D.W., Morgan, T.M. et al. Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J. Am. Coll. Cardiol. 2001, 38(3), p. 796-802.

30. Arques, S., Ambrosi, P., Gelisse, R. et al. Hypoalbuminemia in elderly patients with acute diastolic heart failure. J. Am. Coll. Cardiol. 2003, 42(4), p. 712-716.